|
See related Xyzal film-coated tab information |
|
|
|
Manufacturer |
GlaxoSmithKline |
|
Distributor |
Olic |
|
Contents |
Levocetirizine diHCl |
|
Indications |
Symptomatic treatment of seasonal allergic rhinitis (including ocular symptoms), perennial & persistent allergic rhinitis; chronic urticaria.
Click to view Xyzal detailed prescribing infomation |
|
Dosage |
Adult & childn ≥6 yr 5 mg daily.
Click to view Xyzal detailed prescribing infomation |
|
Overdosage |
View Xyzal overdosage for action to be taken in the event of an overdose. |
|
Administration |
May be taken with or without food |
|
Contraindications |
Hypersensitivity to piperazine derivatives. Severe renal impairment (CrCl <10 mL/min).
Click to view Xyzal detailed prescribing infomation |
|
Special Precautions |
Alcohol consumption, galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Pregnancy & lactation.
Click to view Xyzal detailed prescribing infomation |
|
Adverse Drug Reactions |
Dry mouth, headache, fatigue, somnolence, asthenia, rhinitis, pharyngitis, abdominal pain, migraine.
View ADR Monitoring Form |
|
Side Effects |
View Xyzal side effects |
|
Drug Interactions |
Alcohol, CNS depressants.
View more drug interactions with Xyzal |
|
Pregnancy Category (US FDA) |
Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters). |
|
Storage |
View Xyzal storage conditions for details to ensure optimal shelf-life. |
|
Mechanism of Action |
View Xyzal mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
